Literature DB >> 3373067

Staphylococcus aureus--human endothelial cell interactions.

F D Lowy1, J Fant, L L Higgins, S K Ogawa, V B Hatcher.   

Abstract

Staphylococcus aureus is an invasive pathogen capable of causing life-threatening disease. A major component of this pathogen's virulence is its ability to invade normal endovascular tissue. We examined the interaction of S. aureus with cultured human endothelial cells and with human and rabbit endovascular tissue. Our ultrastructural study demonstrated a sequence of steps which occurred with staphylococcal invasion of human endothelial cells; adhesion, endocytosis, and intracellular replication. Ultimately, this resulted in cell disruption and death. Cytochemical staining of lysosomes demonstrated lysosomal fusion with both viable and killed intracellular bacteria without evidence of staphylococcal degradation. Quantitative studies using an in vitro infection assay demonstrated comparable rates of adhesion by viable and ultraviolet-killed bacteria, phagocytosis at a slower rate, and intracellular replication. The present study demonstrates an active role for the endothelial cell in the development and spread of endovascular staphylococcal infections. It also supports the use of this in vitro tissue culture system as a model for the study of bacterial invasion of the endothelium.

Entities:  

Mesh:

Year:  1988        PMID: 3373067     DOI: 10.1016/s0889-1605(88)80906-6

Source DB:  PubMed          Journal:  J Ultrastruct Mol Struct Res        ISSN: 0889-1605


  24 in total

1.  Phagolysosomal integrity is generally maintained after Staphylococcus aureus invasion of nonprofessional phagocytes but is modulated by strain 6850.

Authors:  Thiên-Trí Lâm; Bernd Giese; Deepak Chikkaballi; Anika Kühn; Wanja Wolber; Jan Pané-Farré; Daniel Schäfer; Susanne Engelmann; Martin Fraunholz; Bhanu Sinha
Journal:  Infect Immun       Date:  2010-06-07       Impact factor: 3.441

2.  Staphylococcal alpha-toxin is not sufficient to mediate escape from phagolysosomes in upper-airway epithelial cells.

Authors:  Bernd Giese; Silvia Dittmann; Kerstin Paprotka; Katja Levin; Annett Weltrowski; Diana Biehler; Thiên-Trí Lâm; Bhanu Sinha; Martin J Fraunholz
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

Review 3.  Taming the Triskelion: Bacterial Manipulation of Clathrin.

Authors:  Eleanor A Latomanski; Hayley J Newton
Journal:  Microbiol Mol Biol Rev       Date:  2019-02-27       Impact factor: 11.056

4.  A human endothelial cell membrane protein that binds Staphylococcus aureus in vitro.

Authors:  D C Tompkins; V B Hatcher; D Patel; G A Orr; L L Higgins; F D Lowy
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

5.  Bacterial species- and strain-dependent induction of tissue factor in human vascular endothelial cells.

Authors:  M H Veltrop; H Beekhuizen; J Thompson
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

6.  Monocytes augment bacterial species- and strain-dependent induction of tissue factor activity in bacterium-infected human vascular endothelial cells.

Authors:  M H Veltrop; J Thompson; H Beekhuizen
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

7.  Internalization of Staphylococcus aureus by endothelial cells induces apoptosis.

Authors:  B E Menzies; I Kourteva
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

8.  Binding of heparan sulfate to Staphylococcus aureus.

Authors:  O D Liang; F Ascencio; L A Fransson; T Wadström
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

9.  Cloning, expression, and mutagenesis of phosphatidylinositol-specific phospholipase C from Staphylococcus aureus: a potential staphylococcal virulence factor.

Authors:  S Daugherty; M G Low
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

10.  Gamma interferon confers resistance to infection with Staphylococcus aureus in human vascular endothelial cells by cooperative proinflammatory and enhanced intrinsic antibacterial activities.

Authors:  Henry Beekhuizen; Joke S van de Gevel
Journal:  Infect Immun       Date:  2007-09-24       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.